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ESVI ratio (-0.32i1.7 vs. +0.9*2.7 g/cm2 per mUm2, P=O.O3). Within the MVP group, 
those treated with angiotensin-converting enzyme inhibitors (ACE-I, n=50) compared to 
those untreated (n=53) had adjusted for the change rn MR degree, regression of ESVI (- 
0.5*12 vs. +6.4*18 ml/m2, P=O.O2), LVMI (-8228 vs. +3.3&?6, P=O.O2) improvement in 
EF (c2t8 vs. -2+8%, P&02) and decline in ESWS (-11+32 vs. +4+34 g/cm2). 
Conclusion: In patients with organrc MR, LV remodeling development is measurable 
and characterized by increase in LV volume and decrease in LV mass to volume ratio. 
Patients with MVP develop more LV remodeling than those without MVP, particularly 
with measurable decline in LV function. Patients treated by ACE-1 show dissociated 
effects LV remodeling suggesting that the long-term effect of these medications should 
be carefully evaluated. 
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1109MP-163 Echocardiographic Quantification of Annular Dilatation 
and Papillary Muscle Separation in Patients of 
Functional Mitral Regurgitation: Role of Anterior Mitral 
Leaflat Length as Reference 
Vincd Jorapur, Richard Lucariello, New York Medical College, Valhalla, NY 
Background: Management of functtonal mitral regurgitation (FMR) may be optimized by 
quantification of the extent of annular dilatation and papillary muscle separation. We 
hypothesized that anterior mitral leaflet length (ALL) does not ddfer significantly between 
normals and patients with systolic left ventricular dysfunction (LVD) and hence may be 
used es a reference measure to quantify annular dilatation and papillary muscle separa- 
tion. 
Method: 50 controls and 30 patients with LVD, of whom 15 had no or mild MR (effective 
regurgitant orifice area - ERO by flow convergence ~0.2) and 15 had moderate or severe 
MR (EROa.2) were prospecttvely studled by echocardiographic measurement of ALL, 
annular diameter (AD), AD/ALL Index. tnterpapillary distance (IPD), IPD/ALL Index, LV 
end diastolic dimension (LVED) and ejectron fraction (EF). 
Results: 
Controls LVD 
ALL 1.89*0. 1.80*0. 
38 29 
AD 1.62*0. 1.99+0. 
27 27 
ADI 0.87+0. 1.13+0. 
ALL 17 23 
IPD 1.49*0. 2.4&O. 
24 56 
IPD/ 0.81+0. 1.42+0. 
ALL 11 39 
LVED 4.29+0. 5.82+0. 
51 73 
LV EF 0.73iO. 0.3+0.0 
09 7 
P LVD No/Mild LVD Moderate/Severe 
MR MR 
0.22 1.84*0.31 1.75*0.29 
<O.OOO 1.99iO.28 
1 
~0.000 1.1+0.24 
<O.OOO 2.02+0.36 2.91*0.3 
<o.ooo 1.15*0.3 1.69AO.28 
<o.ooo 5.37*0.57 6.3eO.59 
<o.ooo 0.34io.05 
1.99*0.24 
1.16iO.22 0.25 
P 
0.43 
0.5 
co.ooo 
1 
co.ooo 
1 
<o.ooo 
0.26iO.05 <o.ooo 
1 
1. No significant difference in ALL among the three groups. 2. Mean AD/ALL Index 1.26 
times and 1.33 times controls in LVD with and without significant MR, respectively. 3. 
Mean IPDIALL Index 1.42 times and 2.1 times controls in LVD with and without signifi- 
cant MR. respectively. 
Conclusion: 1. ALL can be used es a reference measurement to quantify annular dilata- 
tion and papillary muscle separation in patients of FMR. 2. Stgnificant FMR is associated 
with greater extent of papillary muscle separation than annular dilatation. 3. Extent of 
papillary muscle separation, but not of annular dilatation, differs significantly between 
LVD with and without significant FMR. 
12:12 p.m. 
1109MP-164 Development of Left Ventricular Remodeling in Mitral 
Regurgitation: Influence of Etiology and Treatment 
Maurice L. Enriauez-Sarano, Michael Bellamy, Arsene Basmadjlan, David Messika- 
Zeitoun, Maryann Capps, Mayo Clinic, Rochester, MN 
Background: Mitral Regurgitatron (MR) causes left ventricular (LV) remodeling which IS 
a harbinger of LV dysfunction and of poor outcome. How LV remodeling progresses 
remains unknown es sequentral quantitative studies are not available. 
Methods: In 121 patients with organrc MR (age 64*14 years, 69% male) LV remodeling 
was quantified by echocardiography es LV end-diastolic and end-systolic volume indices 
(EDVI, ESVI), ejection fraction (EF). mass index (LVMI) and end-systolic wall stress 
(ESWS) at diagnosis and 574+455 days later The MR effective regurgitant orifice was 
36+22 mm2 
Results: Overall, there was significant development of LV remodeling with EDVI increas- 
ing from 107+24 to 114+31 mUm2 (+7.6*20 ml/m2. P<O.OOl). As no change in LVMI 
were noted, the ratio LVMIIEDVI decreased from 1 .18t0.31 to 1 .l 1+0.28 glmL (change 
0.07eO.33. P=O.O4). However, development of LV remodeling was much greeter tn 
patients with mitral valve prolapse (MVP, n=l03) than in those without MVP (1x18) with 
larger change I” EDVI (+8.7+20 vs. +1.5+19 mUm2, P=O.O3). and in ESVI (+3*16 vs. 
2.2*12 mUm2, P=O.O4). With no difference in LVMI, the ratio LVMI/EDVI declined more 
in MVP (-0.10*0.3? vs. +0.07+0.31 glmL, P=O.O6). Furthermore, unfavorable change in 
LV function was noted in MVP. measured es EF (+0.2+8 vs. +3.3*8, P=O.O3) or ESWS/ 
1109MP-165 Subclinical Aortic Valve Sclerosis Associates With 
Early Atherosclerotic Changes of Carotid Artery 
Tomomi Nishide Yasuko Yamaura, Nozomi Watanabe, Takashi Akasaka, Kiyoshi 
Yoshida. Graduate School of Medicine, Kobe University, Kobe, Japan, Kawasaki Medical 
School, Kurashiki, Japan 
Background: Recent studies suggest that aortic valve sclerosis (AVS) and atherosclero- 
sis share the wmmon pathophygiologic process. However, little is known about the 
association of degenerative changes on the carotid artery and aortic valve in the early 
stages. We examined the relationship between early carotid atherosclerosis and subclin- 
ical AVS in the general populatton. 
Methods: One hundred forty-one healthy adults (aged 24-79. 65 male) in a geographi- 
cally defined area underwent transthoracic echocardiography and carotid ultrasonogra- 
phy. AVS was defined as highly-echogenic irregular thickening on at least one aortic 
valve leaflet. Intimal-medial thickness (IMT) was measured at bilateral common carotid 
arteries and carotid bulbs to assess atherosclerosis. The mean values of the bilateral 
maximum IMT (IMTmax) were calculated. 
Results: No one had clinically significant aortic valve stenosis, regurgitation or carotid 
artery stenosis. AVS was present in 34 subjects (24 %, 20 male). IMTmax was signifi- 
cantly greater in the subjects with AVS (1.31+0.46 vs. 0.84+0.30mm, ~~0.04) after 
adjustment for standard cardiovascular risk factors. IMTmax over 1 .OOmm was related to 
an increased risk of AVS (adjusted odds ratio; 4.6, 95% Confidence Interval; 1.4-14.7). 
Conclusions: Subclinical AVS was associated with early atherosclerotic changes of the 
carotid artery in the general population, suggesting that similar pathogenesis of athero- 
sclerosis contributes to AVS even in the early stages. 
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1109MP-166 The Effect of Losartan Versus Atenolol on Aortic Valve 
Sclerosis: A LIFE Study 
Michael H. Olsen, Kristian Wachtell, Jonathan N. Belle, Kurt Boman. Eva Gerdts, 
Vasilios Papademetriou, Markku S. Nteminen, Jens Rokkedat Bjdrn Dahldf, Richard B. 
Devereux, Glostrup University Hospital, Copenhagen, Denmark, The Weill Medtcal 
College of Cornell University, New York, NY 
Background: We have demonstrated that aortic valve (AV) sclerosis predicts cardiovas- 
cular events independent of traditional risk factors, suggesting AV sclerosis is a marker 
of susceptibility to different atherogenic factors. Because losartan reduced the incidence 
of stroke more than atenolol, we hypothesized that losartan would prevent progressron of 
AV sclerosis es compared to atenolol. Methods: After two weeks of placebo treatment, 
clintcal, laboratory and echocardiographic variables were assessed in 960 hypertensive 
patients with ECG left ventricular (LV) hypertrophy without known AV stenosis, aged 55. 
80 (mean 66+7) years. The patients were included in the LIFE Study and randomized to 
atenolol- or losartan-based regrmes. Echocardiography was performed again after one 
and four years of treatment. AV sclerosis was defined as valve thrckening or calcification. 
Results: At baseline, 388 patients (40.4%) had AV sclerosis and 15 (1.6%) had mild AV 
stenosis. The prevalence of AV sclerosis and mild AV stenosis increased after one year 
of treatment to 52.3% and 2.4% (P<O.OOl) and increased further after four years of treat- 
ment 63.2% and 4.1% (PsO.001). The prevalence of AV sclerosis and AV stenosrs were 
Independent of randomization to losartan or atenolol treatment (year 1: 51.3 vs. 53.4%, 
NS and year 4: 63.6 vs. 62.5%. NS) (year 1: 2.7 vs. 2.1%. NS and year 4: 4.8 vs. 3.2%, 
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NS). However, patients developing AV sclerosis after inclusion had higher mean diastolic 
blood pressure after four years of treatment (83 vs. 80 mmHg, P<O.Ol). The incidence of 
AV stenosis was higher in patients with AV sclerosis compared to those with normal 
valves at baseline after one year (2.8% vs. 0.4%, PcO.001) and four years (6.9% vs. 
0.9%, P-=0.001) of treatment. Conclusion: The prevalence of AV sclerosis and mild AV 
stenosis increased quickly in an elderly high-risk hypertensive population and could not 
be prevented by treatment with losartan. Development of new AV sclerosis or stenosis 
was associated with suboptimal diastolic blood pressure control. Pabents with AV sclero- 
sis had significantly higher risk of progressing to mild AV stenosis, suggesting that AV 
stenosis often is preceded by sclerosis in hypertension. 
12:48 p.m. 
1 IOSMP-167 Association of Cardiovascular Risk Factors to Aortic 
Valve Calcification as Quantified by Electron Beam 
Tomography 
Karsten Pohle, Merle Starke, Ralph MBffert, Dieter Ropers, Werner G. Daniel, Stephan 
Achenbach, University of Erlangen, Erlangen, Germany 
Electron beam tomography (EBT) allows the detection and exact quantification of calcifi- 
cations in coronary vessels (CC) and in the aortic valve (AVC). The aim of this study was 
to analyze the association of cardiovascular dsk factors, CC and AVC. 
Methods: We analyzed cardiac EBT data sets of 1000 consecutive patients (57.1+/-10 
years, 69% men) without an established diagnosis of coronary artery disease, which had 
been obtained for the detection of CC on an outpatient basis. In all patients, atheroscle- 
rotic risk factors (hyperlipidaemia [HL], hypertension [HTN], diabetes [DM], smoking) 
were documented. In all EBT studies, the amount of CC (“Agatston Score”) and of AVC 
(volumetric score) was measured. 
Results: In 17.7% of patients, AVC were found (volume score 41.6+/-219 mma). In 
82.9%, CC were present (Agatston Score 270.3+/s615). The amount of AVC and CC 
showed a weak but statistically significant correlation (wO.21, p<O.OOl). AVC were more 
frequently found in patients with CC as compared to patients without CC (20.5% vs. 
3.8%. pcO.OOl), in patients with HL [19.5% vs. 6.5%. p<O.OOl], HTN [21.7% vs. 13.9%, 
p=O.Ol] and DM [30.7% vs. 16.6%, p=O.O02]. No statistically significant correlation was 
observed for smoking [19.4% vs. 15.6%, p=O.ll]. AVC were found in 2.4% of patients 
without atherosclerotic risk factors, but in 33.3% of patients presenting all 4 nsk factors 
(pcO.001). The mean volume of AVC was significantly increased in patients with HL 
(48.0+/-237mm3 vs. 5.7 33mti, p<O.OOl) and DM (93.9+/-379mm9 vs. 37.5+/-201mm3, 
p=O.O3), while no such relationship was observed for smoking (46.0+/-222mm3 YS. 36.3+/ 
-216mm3, p=O.2) and HTN (52.1+/-259mm3 vs. 32.5+/-176mm3, p=O.l). 
Conclusion: In this study, a significant association was found between atherosclerotic 
risk factors, coronary calcifications and the presence and amount of calcifications of the 
aortic valve. 
1 :oo pm. 
1109MP-168 Risk Stratification in Mild and Moderate Aortic Stenosis 
by Assessment of Aortic Valve Calcification 
Raphael Rosenhek Ursula Klaar, Christine Scholten, Maria Heger, Harald Gabriel, 
Thomas Binder, Gerald Maurer, Helmut Baumganner, University of Vienna, Vienna, 
Austria 
Background: The degree of aortic valve calcification (AV-Calc) has been shown to be a 
significant predictor of outcome in severe aortic stenosis (AS). In addition, aortic sclero- 
sis has recently been reported to be associated with increased mortality. However, it 
remains unknown whether the,degree of AV-Cald is of prognostic value in mild and mod- 
erate AS. 
Methods: 176 consecutive pts. (73 F, age 58+/-19 yrs) with mild to moderate AS (peak 
aortic jet velocity (AV-Vel) between 2.5 and 4.0 m/s) were followed for 5lil8 mths. The 
degree of AV-Calc and other risk factors were assessed. The rate of hemodynamic pro- 
gression was determined and the clinical outcome analyzed. 
Results: During follow-up, 15 cardiac and 19 non-cardiac deaths occurred. Mortality was 
1.8 times higher than that of an age and gender _ matched control population (p<.OO5). 
Kaplan-Meier event-free survival for the entire pt. group, with endpoints defined as death 
(n=34) or aortic valve surgery (n=33) was 95+/-2 % at 1 yr, 75+/-3 % at 3 yrs. and 60+/-5 
% at 5 yrs. By multivariate analysis, moderate or severe AV-Calc, coronary artery dis- 
ease (CAD) and AV-Vel at entry were significant independent predictors of outcome 
(p<.OoOl, p<.OOl and pc.01, respectively). Event-free survival for patients with moderate 
or severe AV-Calc was 92+/-4% at 1 yr, 61+/-7% at 3 and 42+/-7% at 5 yrs versus 1 OO%, 
90+/-4% and 82+/-5% for patients with no or mild AV-Cak. Diabetes, hypercholesteremia 
and hypertension did not predict outcome. The rate of hemodynamic progression was 
significantly faster for pts. with event (0.43+/-0.04 m/s/yr) than for those without (0.14+/- 
0.02 m/s/yr, pc.0001). Of 129 pts. with a follow-up echocardiographic exam, 59 (46%) 
developed severe AS during follow-up. 
Conclusion: Rapid progression to severe AS and an increased mortality have to be con- 
sidered in mild and moderate AS. Particularly pts. with significant AV-Calc but also those 
with CAD and pts. with a rapid progression of the AV-Vel have a poor outcome. Serial 
Doppler studies and the assessment of AV-Cak are important for the management of 
these pts. as they identify high-risk pts. who require closer follow-up than currently rec- 
ommended. 
1109MP-169 
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Relation of Mitral Annular Calcification to 
Cardiovascular Risk Factors and Cardiovascular 
Mortality in Adults With Type 2 Diabetes: The Strong 
Heart Study 
Jennrfer E. Liu New York Hospital Weill Cornell Medical Center, New York, NY 
Background: Mitral annular calcificatron (MAC) is frequently seen on routine echocardio- 
gram in adults with type II diabetes (DM). However, whether MAC is associated with car- 
diovascular (CV) risk factors and subsequent CV events is not well defined. Methods: We 
compared two groups of DM American Indians based on the presence (n= 182) or 
absence (n= 1278) of MAC on echocardiogram. Results: DM with MAC were older (63 
vs. 60 years) with higher systolic blood pressure(l36 vs 133 mm Hg), higher total choles- 
terol (193 vs. 188 mg/dl) and higher urinary creatinine/albumin ratio (uacr) (1093 vs. 698, 
all p<O.OOl) as compared to DM without MAC. There was no difference in gender, body 
mass index or prevalence of smoking. DM with MAC had higher left ventricular (LV) 
mass (176 vs. 181 gm), higher prevalence of LV hypertrophy (18 vs. 10%) lower stress- 
corrected midwall shortening (98 vs. 103%) and lower mitral E/A ratio (0.75 vs. 0.81, all 
p<O.O05) as compared to DM without MAC. The prevalence of coronary heart disease 
and CV mortality and total mortality are as shown. 
On multivariate analysis adjustrng for age, systolic blood pressure, cholesterol and uacr, 
MAC was not found to be independently associated with prevalence of coronary heart 
disease, CV and total deaths. CONCLUSION: MAC is associated with abnormal LV 
structure and function in the DM population. The higher prevalence of coronary heart dis- 
ease and a higher total mortality in DM with MAC IS likely mediated by a larger burden of 
CV risk factors 
Prevalence of coronary heart disease 
No MAC 
7.2% 
MAC P value 
11.7% 0.03 
CV Death 3.9% 
All Death 8.3% 
1109MP-170 Impact of Systolic Hypertension and Impedance 
Lowering Drugs on Clinical Outcomes in Chronic 
Severe Aortic Regurgitation 
2.4% NS 
13.1% 0.05 
1:24 p.m. 
Phyllis G. Supine, Jeffrey S. Borer, Glare A. Hochreiter, Edmund M. Herrold, Richard B. 
Devereux, Mary J. Roman, Paul D. Kligfield, Elaine Dillingham, Weill Medical College of 
Cornell University, New York, NY 
Background: The prevalence of systolic hypertension (HTN) coexisting with aortrc regur- 
gitation (AR) and the impact of HTN on AR natural history are poorly defined. Such data 
are important: previous trials of impedance lowering drugs (ILRx) for AR were done 
largely in pts with HTN and suggest improvement in LV size and function. However, few 
data have elucidated ILRx effect on clinical outcome and ILRx effect in AR without HTN 
is unknown. To explore these issues, we retrospectively reviewed our ongoing prospec- 
tive study of AR natural history and outcome predictors. 
Methods: Among 73 unoperated pts with chronic severe AR (83% male, 44*15 yrs old at 
entry) who entered the study asymptomatic with normal LV ejection fraction (EF) at 
rest(r), we related HTN (history and/or study entry systolic blood pressure>l40) to subse- 
quent cardiac events (CE) during 7+4 event-free yrs. We also evaluated ILRx effect in pts 
with and without HTN. 
Results: At study entry, 29/73(40%) pts had HTN; 17/29(59%) pts with HTN and 3/ 
44(7%) without HTN were taking ILRx chronically (not protocol-mandated): diuretics(8 
pts), ACE inhibitors(5 pts), direct vasodilators(4 pts), combination ILRx(3 pts). During fol- 
lowup, 2 pts died suddenly, 17 pts developed CHF f subnl LVEFr and 5 developed subnl 
LVEFr alone. HTN predicted increased risk of CE (9.2%/yr vs 3.2%&r without HTN, 
p=.OO2) and remained predictive after adjustment for age and gender (p.z.02). Among pts 
with HTN. risk for CE was 4-fold greater in pts taking ILRx chronically(l5.5%/yr) vs those 
without chronic ILRx use(3.7%/yr, pc.02); among pts without HTN, risk was 0% with ILRx 
vs.3%/yr without (NS) but small subgroup size limits inferences in these pts. 
Conclusions: Systolic HTN occurs frequently in asymptomatic pts with chronic severe AR 
and portends a poor clinical outcome. Data were insufficient to evaluate individual drug 
classes but ILRx as a group do not mitigate the impact of HTN; at least some of these 
drugs may be deleterious. ILRx effect in pts without HTN remains unclear. Future 
research must determine why theoretically beneficial ILRx was ineffective for clinical out- 
come and, specifically, whether drug class, dose, etc., interact with clinical effect. 
I:36 pm. 
1109MP-171 Early Predictors of Mortality in Patients With 
Endocarditis 
Vivian Chu Christopher Cabell, Erin Kuniholm, Danny Benjamrn, John Engemann, Laura -1 
Meyer, Vance Fowler, Andrew Wang, Duke University Medical Center, Durham, NC 
Background: Infective endocarditis (IE) is associated with significant mortality, but prog- 
nostic factors remain poorly defined. We evaluated early prognostic factors in patients 
with IE, including severity of illness, to determine those independently associated with 
death. 
Methods: Clinical, microbrologic and echo data of patients with definite or possible IE by 
Duke criteria from 1996.2001 (n=351) were collected prospectively in the Duke IE data- 
